'Quadrapeutics' works in preclinical study of hard-to-treat tumors: Animal tests show technology effective against aggressive cancer

The first preclinical tests for a novel anti-cancer technology called 'quadrapeutics' that converts current clinical treatments to instantaneously detect and kill only cancer cells have been successful. Quadrapeutics combines clinically available drugs, colloidal gold, pulsed lasers and radiation in a novel and safe micro-treatment that improved standard therapy by 17-fold against aggressive, drug-resistant tumors.